Zika virus is a mosquito-borne virus that causes fever, rash and joint pain. It was first discovered in Uganda in 1947 and has since spread to many other countries. It is transmitted primarily via the bites of infected Aedes mosquitoes. While most cases are mild, infection during pregnancy can cause microcephaly in babies. Currently there is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and protecting against mosquito bites.
The document discusses the Zika virus, including its transmission, symptoms, effects, origin and spread. It notes that Zika is spread primarily through bites from Aedes aegypti mosquitoes and details some of its alarming effects such as microcephaly in newborns. The virus originated in Africa in 1947 and has since spread throughout Africa, Asia and the Americas.
The Zika virus was discovered in Africa in 1947 and can cause mild illness, but its emergence in the Americas has coincided with a marked increase in microcephaly. Microcephaly is a birth defect where the baby's head is much smaller than expected and is associated with problems in brain development. Studies of the Zika outbreak in French Polynesia from 2013-2014 found that the risk of microcephaly was about 1% for mothers infected during the first trimester of pregnancy. While this risk appears low, a very high percentage of people were infected during Zika outbreaks, so it remains an important public health issue despite the relatively low risk for any individual fetus.
The document discusses Brazil's experiences with the Zika virus outbreak in Pernambuco from 2015-2016. It describes how an initial outbreak of rash was later confirmed to be Zika virus in July 2015. Later that year, cases of Guillain-Barré syndrome and microcephaly in newborns increased, associated with Zika infections months prior. Surveillance efforts successfully monitored the outbreak through syndromic and universal case reporting, as well as sentinel laboratory testing of pregnant women and newborns. Challenges remained in differentiating Zika from other co-circulating viruses like dengue and chikungunya.
This presentation summarizes what we know as of 10/27/16 about the connection between Zika virus and microcephaly, and what advice physicians could provide for their patients who are currently pregnant, or planning a pregnancy
Zika virus poses risks to communities in Puerto Rico and parts of the US. Community health centers are responding by screening pregnant patients, educating communities on risks and prevention, and distributing prevention kits. The National Association of Community Health Centers can help by providing educational materials, lobbying for vaccine development, and raising awareness among clinicians. Coordinated responses are needed due to the threat of local transmission and travel between high-risk areas.
This document provides information about the Zika virus. It discusses that Zika is primarily spread through mosquito bites and can also be sexually transmitted. While many infected people have no or mild symptoms, Zika infection during pregnancy can cause microcephaly and other birth defects. The document provides details on symptoms, testing, treatment, prevention recommendations, and ongoing surveillance of Zika cases.
Zika virus is an emerging mosquito-borne virus first isolated in Uganda in 1947. It is related to dengue, yellow fever and West Nile viruses. Major outbreaks occurred in 2007 in Yap Islands, 2013 in French Polynesia, and 2015 in Brazil. Bangladesh reported its first case in 2016. Zika virus is transmitted primarily via Aedes mosquitoes and can also be transmitted sexually and from mother to fetus. Infection often causes mild fever and rash but can result in Guillain-Barre syndrome in adults and microcephaly in infants born to infected mothers. Diagnosis involves virus detection, IgM antibody tests and PRNT. There is no vaccine or treatment, so prevention focuses on mosquito
Zika virus is a mosquito-borne virus that causes fever, rash and joint pain. It was first discovered in Uganda in 1947 and has since spread to many other countries. It is transmitted primarily via the bites of infected Aedes mosquitoes. While most cases are mild, infection during pregnancy can cause microcephaly in babies. Currently there is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and protecting against mosquito bites.
The document discusses the Zika virus, including its transmission, symptoms, effects, origin and spread. It notes that Zika is spread primarily through bites from Aedes aegypti mosquitoes and details some of its alarming effects such as microcephaly in newborns. The virus originated in Africa in 1947 and has since spread throughout Africa, Asia and the Americas.
The Zika virus was discovered in Africa in 1947 and can cause mild illness, but its emergence in the Americas has coincided with a marked increase in microcephaly. Microcephaly is a birth defect where the baby's head is much smaller than expected and is associated with problems in brain development. Studies of the Zika outbreak in French Polynesia from 2013-2014 found that the risk of microcephaly was about 1% for mothers infected during the first trimester of pregnancy. While this risk appears low, a very high percentage of people were infected during Zika outbreaks, so it remains an important public health issue despite the relatively low risk for any individual fetus.
The document discusses Brazil's experiences with the Zika virus outbreak in Pernambuco from 2015-2016. It describes how an initial outbreak of rash was later confirmed to be Zika virus in July 2015. Later that year, cases of Guillain-Barré syndrome and microcephaly in newborns increased, associated with Zika infections months prior. Surveillance efforts successfully monitored the outbreak through syndromic and universal case reporting, as well as sentinel laboratory testing of pregnant women and newborns. Challenges remained in differentiating Zika from other co-circulating viruses like dengue and chikungunya.
This presentation summarizes what we know as of 10/27/16 about the connection between Zika virus and microcephaly, and what advice physicians could provide for their patients who are currently pregnant, or planning a pregnancy
Zika virus poses risks to communities in Puerto Rico and parts of the US. Community health centers are responding by screening pregnant patients, educating communities on risks and prevention, and distributing prevention kits. The National Association of Community Health Centers can help by providing educational materials, lobbying for vaccine development, and raising awareness among clinicians. Coordinated responses are needed due to the threat of local transmission and travel between high-risk areas.
This document provides information about the Zika virus. It discusses that Zika is primarily spread through mosquito bites and can also be sexually transmitted. While many infected people have no or mild symptoms, Zika infection during pregnancy can cause microcephaly and other birth defects. The document provides details on symptoms, testing, treatment, prevention recommendations, and ongoing surveillance of Zika cases.
Zika virus is an emerging mosquito-borne virus first isolated in Uganda in 1947. It is related to dengue, yellow fever and West Nile viruses. Major outbreaks occurred in 2007 in Yap Islands, 2013 in French Polynesia, and 2015 in Brazil. Bangladesh reported its first case in 2016. Zika virus is transmitted primarily via Aedes mosquitoes and can also be transmitted sexually and from mother to fetus. Infection often causes mild fever and rash but can result in Guillain-Barre syndrome in adults and microcephaly in infants born to infected mothers. Diagnosis involves virus detection, IgM antibody tests and PRNT. There is no vaccine or treatment, so prevention focuses on mosquito
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
Zika is a mosquito-borne virus spread through the bites of Aedes aegypti mosquitoes, the same species that transmits dengue and chikungunya. It was first identified in Africa in 1947 and has since spread to Southeast Asia, the Pacific Islands, and the Americas. Infection with Zika virus often causes mild fever and rash, but can result in neurological disorders in newborns if mothers are infected during pregnancy. There is no vaccine or treatment currently available.
This document summarizes the history and spread of the Zika virus. It was first isolated in 1947 in Uganda and has since had outbreaks in Africa, Southeast Asia, the Pacific Islands and most recently the Americas. The virus is transmitted by Aedes mosquitoes and causes mild fever, rash and joint pain in most cases. There is growing evidence linking Zika infection during pregnancy to microcephaly and other birth defects. As of late 2015, Brazil was experiencing a major outbreak with over 1,000 reported cases of microcephaly. There is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and using insect repellent.
What Insurers Can Learn From the Zika Outbreak Gen Re
In the weeks leading up to the 2016 Summer Olympic Games, a few athletes announced they would forgo the games for fear of contracting the Zika virus in Brazil. There’s a good chance athletes aren’t the only ones avoiding traveling to South America. While Zika presents with very minor symptoms that sometimes go unnoticed in adults, it can lead to microcephaly for infants born from mothers who have contracted it.
Read more here: http://www.genre.com/knowledge/blog/
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
The document summarizes information about Zika virus including its structure, taxonomy, genome, replication cycle, transmission, signs and symptoms, diagnosis, treatment and prevention. It describes Zika virus as a flavivirus transmitted by Aedes mosquitoes that can cause mild fever and rash. The document highlights the association between Zika infection in pregnant women and microcephaly in babies. It provides details on detecting the virus in different samples like serum, urine and semen using RT-PCR and challenges in diagnosis. The need for public alerts, travel guidance and testing is emphasized.
Zika virus is transmitted by daytime-active Aedes mosquitoes and can cause mild fever and rash in humans. It emerged as a global health concern in 2015 when infection during pregnancy was linked to microcephaly and other birth defects. There is no vaccine or treatment, so prevention focuses on avoiding mosquito bites.
Zika virus is transmitted by daytime-active Aedes mosquitoes and was first isolated in 1947 in Uganda. It causes a mild illness with symptoms like fever, rash, joint pain, and conjunctivitis lasting 2-7 days. There is no vaccine or specific treatment, though symptoms can be treated with rest, fluids, and common fever and pain medications. The virus has recently spread explosively and is a concern due to links to birth defects like microcephaly. Ongoing research aims to develop vaccines to address this emerging public health threat.
Zika virus is transmitted primarily through the bite of infected Aedes mosquitoes and can cause fever, rash, joint pain, and conjunctivitis. While usually mild, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have recently occurred in Brazil, the Americas, and the Pacific. Diagnosis involves virus detection or antibody testing, but results can be complicated by cross-reactivity with other flaviviruses like dengue.
The document summarizes information about the Zika virus outbreak, including that it is spreading explosively in the Americas and Caribbean and has been declared a public health emergency. The virus is transmitted via mosquito bites and sexually and causes mild illness in most cases, but can lead to complications like microcephaly and Guillain-Barre syndrome. Pregnant women infected are at increased risk of fetal complications. While there is no vaccine or treatment, prevention efforts focus on personal protection against mosquitos and safe sexual practices.
The document summarizes information about the Zika virus. It discusses how the World Health Organization declared Zika a public health emergency due to its suspected link to microcephaly. It then provides details about the symptoms of Zika virus, how it is transmitted, diagnosed, prevented, and treated. The document also discusses the WHO and CDC responses to Zika and efforts to develop a vaccine.
This document provides an overview of the Zika virus. It begins with definitions and an introduction to the virus. The history section describes its discovery and spread. Key points include it being first isolated in 1947 in Uganda and recent outbreaks in French Polynesia, Brazil, and other Americas countries. The rest of the document covers epidemiology, clinical features, diagnosis, treatment, prevention, and control of the Zika virus. It provides details on transmission, symptoms, complications like Guillain-Barré syndrome, diagnostic testing, current lack of vaccines or treatment, and recommendations to prevent mosquito bites.
This is the first time in history that ZIKV has been associated with the development of adverse birth outcomes and has been linked to perinatal transmission. Little is known regarding the natural history, epidemiological transmission patterns, and major risk factors associated with ZIKV. Data on the outcomes of pregnancies in ZIKV infected women as well as specific trimesters when pregnant women are at highest risk for developing an adverse birth outcome remains sparse. This presentation discusses the epidemiological background and history of Zika Virus, preventative methods, and risk factors. In addition, the presentation discusses a research proposal to evaluate potential risk factors associated with the development of adverse birth outcomes in pregnant women with a laboratory confirmed diagnosis of ZIKV versus those Zika Virus infected pregnant women that did not develop adverse birth outcomes in three low-income regions of Northeastern Brazil.
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach toward tackling the Zika virus.
The document summarizes information about the Zika virus including its history, transmission, epidemiology, clinical presentation, diagnosis, and management. It notes that Zika virus is spread primarily via the bite of infected mosquitoes and can cause mild fever and rash. The major concern is its potential association with microcephaly in fetuses when a pregnant woman is infected. The CDC and WHO have issued guidelines for pregnant women, including considering postponing travel to outbreak regions.
Updated Lecture about Zika virus .
Currently I am working in Arar Central Hospital, Arar city
In Saudi Arabia
Please do not hesitate to contact us if you require any further information.
Alsultany@hotmail.com
The document discusses the Zika virus. It was discovered in 1947 and is transmitted by Aedes mosquitoes. Symptoms are mild fever and rash. Infection during pregnancy is a risk factor for microcephaly in babies. There is no vaccine or treatment, only symptom management. The virus spread rapidly in the Americas in 2015. Prevention focuses on controlling mosquito populations and avoiding bites during outbreaks. Diagnosis involves virus detection or antibody testing.
The document provides information on the Zika virus, including its history, epidemiology, transmission, signs and symptoms, complications, diagnosis, and current situation. It discusses how the virus was first identified in 1947 in Uganda in monkeys and humans in 1952. It outlines its spread to Africa, Asia, the Pacific islands, and the Americas. It also summarizes Brazil reporting over 500,000 suspected Zika cases and the observed increase in Guillain-Barré syndrome and microcephaly linked to the outbreak.
This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
Zika virus is an emerging mosquito-borne virus that causes mild illness but can lead to microcephaly in infants born to infected mothers. The document summarizes Zika virus transmission, clinical presentation, diagnosis, complications including microcephaly and eye abnormalities in infants, and recommendations for testing pregnant women and infants exposed to Zika. El Niño conditions can help the spread of Zika virus by increasing mosquito populations. Brazil has seen a sharp rise in microcephaly cases linked to Zika virus infection during pregnancy.
Zika virus is primarily spread through the bites of infected Aedes mosquitoes. While Zika infection is usually mild, symptoms can include fever, rash, joint pain, and red eyes. The virus poses a serious risk to pregnant women, as infection during pregnancy has been linked to microcephaly and other severe fetal brain defects in babies. There is no vaccine or treatment for Zika, so prevention focuses on avoiding mosquito bites through protective clothing and repellents when traveling in affected areas.
The document discusses the Zika virus and its risks, especially for pregnant women. It notes that Zika infection during pregnancy can cause microcephaly and other birth defects in the fetus. It provides information on symptoms of Zika and recommends rest, fluids, and acetaminophen to treat symptoms. The best ways to prevent Zika outlined are using insect repellent, wearing long sleeves/pants, staying indoors, and using condoms during sex or mosquito netting for babies.
Neurological and Autoimmune Complications of Zika Virus infection - Slideset ...WAidid
The slideset by Professor Safadi analyses the case control study providing evidence for Zika virus infection causing Guillain-Barré syndrome.
In addition to Zika Virus association with Guillain-Barré syndrome, the slides show new data from endemic areas suggesting that ZIKV may be linked to other neurological outcomes.
Zika is a mosquito-borne virus spread through the bites of Aedes aegypti mosquitoes, the same species that transmits dengue and chikungunya. It was first identified in Africa in 1947 and has since spread to Southeast Asia, the Pacific Islands, and the Americas. Infection with Zika virus often causes mild fever and rash, but can result in neurological disorders in newborns if mothers are infected during pregnancy. There is no vaccine or treatment currently available.
This document summarizes the history and spread of the Zika virus. It was first isolated in 1947 in Uganda and has since had outbreaks in Africa, Southeast Asia, the Pacific Islands and most recently the Americas. The virus is transmitted by Aedes mosquitoes and causes mild fever, rash and joint pain in most cases. There is growing evidence linking Zika infection during pregnancy to microcephaly and other birth defects. As of late 2015, Brazil was experiencing a major outbreak with over 1,000 reported cases of microcephaly. There is no vaccine or treatment, so prevention focuses on eliminating mosquito breeding sites and using insect repellent.
What Insurers Can Learn From the Zika Outbreak Gen Re
In the weeks leading up to the 2016 Summer Olympic Games, a few athletes announced they would forgo the games for fear of contracting the Zika virus in Brazil. There’s a good chance athletes aren’t the only ones avoiding traveling to South America. While Zika presents with very minor symptoms that sometimes go unnoticed in adults, it can lead to microcephaly for infants born from mothers who have contracted it.
Read more here: http://www.genre.com/knowledge/blog/
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
The document summarizes information about Zika virus including its structure, taxonomy, genome, replication cycle, transmission, signs and symptoms, diagnosis, treatment and prevention. It describes Zika virus as a flavivirus transmitted by Aedes mosquitoes that can cause mild fever and rash. The document highlights the association between Zika infection in pregnant women and microcephaly in babies. It provides details on detecting the virus in different samples like serum, urine and semen using RT-PCR and challenges in diagnosis. The need for public alerts, travel guidance and testing is emphasized.
Zika virus is transmitted by daytime-active Aedes mosquitoes and can cause mild fever and rash in humans. It emerged as a global health concern in 2015 when infection during pregnancy was linked to microcephaly and other birth defects. There is no vaccine or treatment, so prevention focuses on avoiding mosquito bites.
Zika virus is transmitted by daytime-active Aedes mosquitoes and was first isolated in 1947 in Uganda. It causes a mild illness with symptoms like fever, rash, joint pain, and conjunctivitis lasting 2-7 days. There is no vaccine or specific treatment, though symptoms can be treated with rest, fluids, and common fever and pain medications. The virus has recently spread explosively and is a concern due to links to birth defects like microcephaly. Ongoing research aims to develop vaccines to address this emerging public health threat.
Zika virus is transmitted primarily through the bite of infected Aedes mosquitoes and can cause fever, rash, joint pain, and conjunctivitis. While usually mild, Zika virus infection during pregnancy can cause microcephaly and other birth defects. The virus was first identified in 1947 and outbreaks have recently occurred in Brazil, the Americas, and the Pacific. Diagnosis involves virus detection or antibody testing, but results can be complicated by cross-reactivity with other flaviviruses like dengue.
The document summarizes information about the Zika virus outbreak, including that it is spreading explosively in the Americas and Caribbean and has been declared a public health emergency. The virus is transmitted via mosquito bites and sexually and causes mild illness in most cases, but can lead to complications like microcephaly and Guillain-Barre syndrome. Pregnant women infected are at increased risk of fetal complications. While there is no vaccine or treatment, prevention efforts focus on personal protection against mosquitos and safe sexual practices.
The document summarizes information about the Zika virus. It discusses how the World Health Organization declared Zika a public health emergency due to its suspected link to microcephaly. It then provides details about the symptoms of Zika virus, how it is transmitted, diagnosed, prevented, and treated. The document also discusses the WHO and CDC responses to Zika and efforts to develop a vaccine.
This document provides an overview of the Zika virus. It begins with definitions and an introduction to the virus. The history section describes its discovery and spread. Key points include it being first isolated in 1947 in Uganda and recent outbreaks in French Polynesia, Brazil, and other Americas countries. The rest of the document covers epidemiology, clinical features, diagnosis, treatment, prevention, and control of the Zika virus. It provides details on transmission, symptoms, complications like Guillain-Barré syndrome, diagnostic testing, current lack of vaccines or treatment, and recommendations to prevent mosquito bites.
This is the first time in history that ZIKV has been associated with the development of adverse birth outcomes and has been linked to perinatal transmission. Little is known regarding the natural history, epidemiological transmission patterns, and major risk factors associated with ZIKV. Data on the outcomes of pregnancies in ZIKV infected women as well as specific trimesters when pregnant women are at highest risk for developing an adverse birth outcome remains sparse. This presentation discusses the epidemiological background and history of Zika Virus, preventative methods, and risk factors. In addition, the presentation discusses a research proposal to evaluate potential risk factors associated with the development of adverse birth outcomes in pregnant women with a laboratory confirmed diagnosis of ZIKV versus those Zika Virus infected pregnant women that did not develop adverse birth outcomes in three low-income regions of Northeastern Brazil.
Shaping the Caribbean's response to Zika, UWI’s Zika Task Force (www.uwi.edu/zika) is gathering and providing expert advice to develop a strategic, scientific approach toward tackling the Zika virus.
The document summarizes information about the Zika virus including its history, transmission, epidemiology, clinical presentation, diagnosis, and management. It notes that Zika virus is spread primarily via the bite of infected mosquitoes and can cause mild fever and rash. The major concern is its potential association with microcephaly in fetuses when a pregnant woman is infected. The CDC and WHO have issued guidelines for pregnant women, including considering postponing travel to outbreak regions.
Updated Lecture about Zika virus .
Currently I am working in Arar Central Hospital, Arar city
In Saudi Arabia
Please do not hesitate to contact us if you require any further information.
Alsultany@hotmail.com
The document discusses the Zika virus. It was discovered in 1947 and is transmitted by Aedes mosquitoes. Symptoms are mild fever and rash. Infection during pregnancy is a risk factor for microcephaly in babies. There is no vaccine or treatment, only symptom management. The virus spread rapidly in the Americas in 2015. Prevention focuses on controlling mosquito populations and avoiding bites during outbreaks. Diagnosis involves virus detection or antibody testing.
The document provides information on the Zika virus, including its history, epidemiology, transmission, signs and symptoms, complications, diagnosis, and current situation. It discusses how the virus was first identified in 1947 in Uganda in monkeys and humans in 1952. It outlines its spread to Africa, Asia, the Pacific islands, and the Americas. It also summarizes Brazil reporting over 500,000 suspected Zika cases and the observed increase in Guillain-Barré syndrome and microcephaly linked to the outbreak.
This document summarizes information about Zika virus infection in pregnancy from several sources:
- Zika virus is transmitted by Aedes mosquitoes and was first isolated in Uganda in 1947. Recent outbreaks have occurred in French Polynesia, Brazil and other parts of the Americas.
- Brazil reported an increase in infants born with microcephaly in 2015 which was linked to Zika virus infection during pregnancy after the virus was detected in amniotic fluid and brain tissue of affected fetuses and infants.
- The CDC provides testing and screening guidelines for pregnant women with travel history or residence in areas with Zika virus transmission to monitor infections and potential fetal impact.
Zika virus is an emerging mosquito-borne virus that causes mild illness but can lead to microcephaly in infants born to infected mothers. The document summarizes Zika virus transmission, clinical presentation, diagnosis, complications including microcephaly and eye abnormalities in infants, and recommendations for testing pregnant women and infants exposed to Zika. El Niño conditions can help the spread of Zika virus by increasing mosquito populations. Brazil has seen a sharp rise in microcephaly cases linked to Zika virus infection during pregnancy.
Zika virus is primarily spread through the bites of infected Aedes mosquitoes. While Zika infection is usually mild, symptoms can include fever, rash, joint pain, and red eyes. The virus poses a serious risk to pregnant women, as infection during pregnancy has been linked to microcephaly and other severe fetal brain defects in babies. There is no vaccine or treatment for Zika, so prevention focuses on avoiding mosquito bites through protective clothing and repellents when traveling in affected areas.
The document discusses the Zika virus and its risks, especially for pregnant women. It notes that Zika infection during pregnancy can cause microcephaly and other birth defects in the fetus. It provides information on symptoms of Zika and recommends rest, fluids, and acetaminophen to treat symptoms. The best ways to prevent Zika outlined are using insect repellent, wearing long sleeves/pants, staying indoors, and using condoms during sex or mosquito netting for babies.
Zika virus is a mosquito-borne virus that causes mild fever and rash. It was first discovered in Uganda in 1947 and recent outbreaks have occurred in the Americas. The virus is transmitted primarily through the bites of infected Aedes mosquitoes. While most infections cause mild symptoms, infection during pregnancy can cause microcephaly and other birth defects. There is no vaccine or treatment currently available, so prevention focuses on reducing mosquito habitat and exposure through clothing and repellents.
Haramaya university Zika Presentation by Ruach BielMedical Student
This Slide share prepared by Group five.
Department of nursing in Ethiopia that give knowledge about CDC and focus on Zika virus and how to be transmitted and prevent. we wish you good luck.
Haramaya university
prepared
By Ruach Biel Reath
Haramaya university Zika Presentation by Ruach BielMedical Student
this slide is prepared by health care student in ethiopia At haramaya university
College of health and medical science
That can give you good knowledge and how to care for patient who came with zika virus prevention and control.
Haramaya university
Prepared by
Ruach Biel Reath
Zika virus is transmitted primarily through the bite of infected Aedes species mosquitoes. Symptoms are usually mild and include fever, rash, joint pain, and red eyes. While Zika infection is generally not dangerous, it can cause birth defects if transmitted from a pregnant woman to her fetus. There is no vaccine or treatment for Zika, so prevention through mosquito bite avoidance is key.
Zika virus was first identified in 1947 in Uganda and can be transmitted via mosquito bites or sexually. Symptoms are usually mild but infection during pregnancy increases risk of birth defects. The document discusses the history and introduction of Zika virus; its current status since the 2015 outbreak in Brazil; signs and symptoms of infection; modes of transmission and diagnosis; treatment involving symptom relief and prevention of mosquito bites or sexual transmission; and concludes with a summary of the key points covered.
Zika virus is a mosquito-borne virus first identified in 1947. It causes mild fever and rash symptoms. Recent outbreaks in Brazil and French Polynesia have been linked to neurological complications like microcephaly in newborns. The virus is transmitted primarily via Aedes mosquitoes and can also be sexually transmitted. While there is no vaccine or treatment, prevention focuses on reducing mosquito habitats and using repellents. Health organizations recommend pregnant women avoid travel to outbreak areas.
The document summarizes the history, transmission, symptoms, treatment and current status of the Zika virus outbreak. It traces the virus from its discovery in monkeys in Uganda in 1947 to the current epidemic affecting over 1.5 million people in South and Central America. The virus is transmitted primarily via mosquito bites from the Aedes species. While symptoms are usually mild, infection during pregnancy can cause microcephaly in fetuses. There is currently no vaccine or cure. The World Health Organization has declared a global health emergency due to the rapid spread of Zika in the Americas and risk to other regions with Aedes mosquitoes, such as Asia and the Philippines. National health authorities are working to limit outbreaks through public advisories and
This document summarizes information about the Zika virus. It describes how the virus is transmitted by Aedes mosquitoes, causes mild fever and rash in most cases but can lead to microcephaly in babies born to infected mothers. It discusses outbreaks in Africa, Asia, and the Americas and the association between Zika infection and Guillain-Barre syndrome. Diagnosis involves testing body fluids for the virus. While there is no vaccine or treatment, prevention focuses on eliminating mosquito breeding sites and protecting against mosquito bites.
The document summarizes information about the Zika virus, including that it is mosquito-borne and can also be sexually transmitted. It notes that while most adult cases are mild, Zika infection during pregnancy can cause microcephaly and other birth defects in babies. The document provides details on symptoms, transmission routes, areas affected, current case numbers in New Jersey, recommendations for pregnant women, and steps individuals can take to prevent Zika infection through mosquito bites and safe sex.
This document provides an overview of Zika virus. It discusses the virus's origin and identification in Uganda in 1947, its isolation from humans in Nigeria in 1954, and outbreaks in Brazil starting in 2015. Symptoms of Zika virus disease are usually mild, but it has been linked to microcephaly in babies born to infected mothers and Guillain-Barré syndrome. The virus is transmitted primarily via Aedes mosquito bites. While no vaccine exists, prevention focuses on avoiding mosquito bites by using insect repellent and protective clothing.
The presentation discusses the Zika virus. It provides an overview of the virus's history, symptoms, transmission, treatment and prevention. The virus is spread primarily via mosquito bites and can cause birth defects if contracted during pregnancy. While symptoms are often mild, it poses neurological risks. Currently, prevention focuses on avoiding mosquito bites and protected sexual contact for those in affected areas. Further research is ongoing to develop a vaccine.
This document provides information about Zika virus from its causes and transmission to symptoms, diagnosis, treatment, and prevention. It is caused by a virus transmitted primarily by Aedes mosquitos and can also be sexually transmitted. While most cases have mild or no symptoms, it poses risks for neurological complications and microcephaly if contracted during pregnancy. There is no vaccine and treatment focuses on relieving symptoms. Prevention emphasizes avoiding mosquito bites through protective clothing and repellent. The WHO is supporting affected countries through surveillance, laboratory testing, clinical guidance, and vector control activities to address the ongoing Zika outbreak.
- Zika virus is an emerging mosquito-borne virus first identified in 1947 in Uganda. It spread widely in 2015-2016 throughout South and Central America and the Caribbean.
- It is transmitted primarily via the bite of infected Aedes mosquitoes. While most cases are asymptomatic, it can cause mild fever and rash. A major concern is its link to microcephaly in babies born to infected mothers.
- There is no vaccine or treatment. Prevention focuses on avoiding mosquito bites through protective clothing and repellents, especially for pregnant women considering travel to outbreak areas.
Zika virus was first isolated in 1947 in Uganda. It spread from Africa to Asia between 1951-1981 and caused its first outbreak outside of Africa and Asia on Yap Island in 2007. In 2015, Zika virus emerged in Brazil and has since spread across South and Central America. The main reasons for the outbreak in the Americas include lack of prior exposure or immunity, presence of the Aedes mosquito vector, and living conditions conducive to mosquito breeding. Zika virus is alarming due to its association with microcephaly in babies born to infected mothers and the lack of vaccines or treatments.
The document provides information about Zika virus from the Fairfax County Health Department. It discusses the epidemiology and clinical presentation of Zika, risks to pregnancy, and strategies for prevention and control. If local transmission was detected, the Health Department would conduct educational outreach and begin mosquito control activities like removing breeding sites, larvicide and pesticide treatments. It emphasizes the role of Aedes mosquitoes and provides tips for residents to eliminate standing water and prevent mosquito bites to help control the spread of Zika.
This document discusses the Zika virus. It provides information on the composition, history, outbreaks, transmission, symptoms, and prevention of the Zika virus. The virus is spread primarily via mosquito bites. While usually causing only mild symptoms, infection during pregnancy can lead to microcephaly in babies. Prevention focuses on avoiding mosquito bites and areas with ongoing transmission.
Nursing management of the patient with Tonsillitis PPTblessyjannu21
Prepared by Prof. Blessy Thomas MSc Nursing, FNCON, SPN. The tonsils are two small glands that sit on either side of the throat.
In young children, they help to fight germs and act as a barrier against infection.
Tonsils act as filters, trapping germs that could otherwise enter the airways and cause infection.
They also make antibodies to fight infection.
But sometimes, they get overwhelmed by bacteria or viruses.
This can make them swollen and inflamed.
Tonsillitis is an infection of the tonsils, two masses of tissue at the back of the throat.
Tonsillitis is inflammation of the tonsils, two oval-shaped pads of tissue at the back of the throat — one tonsil on each side.
Tonsillitis is common, especially in children.
It can happen once in a while or come back again and again in a short period.Nursing management of Tonsillitis is important.
A comprehensive understanding of the operations for management of Tonsillitis and areas requiring special attention would be important.
Health Tech Market Intelligence Prelim Questions -Gokul Rangarajan
The Ultimate Guide to Setting up Market Research in Health Tech part -1
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
This lays foundation of scoping research project what are the
Before embarking on a research project, especially one aimed at scoping and defining parameters like the one described for health tech IT, several crucial considerations should be addressed. Here’s a comprehensive guide covering key aspects to ensure a well-structured and successful research initiative:
1. Define Research Objectives and Scope
Clear Objectives: Define specific goals such as understanding market needs, identifying new opportunities, assessing risks, or refining pricing strategies.
Scope Definition: Clearly outline the boundaries of the research in terms of geographical focus, target demographics (e.g., age, socio-economic status), and industry sectors (e.g., healthcare IT).
3. Review Existing Literature and Resources
Literature Review: Conduct a thorough review of existing research, market reports, and relevant literature to build foundational knowledge.
Gap Analysis: Identify gaps in existing knowledge or areas where further exploration is needed.
4. Select Research Methodology and Tools
Methodological Approach: Choose appropriate research methods such as surveys, interviews, focus groups, or data analytics.
Tools and Resources: Select tools like Google Forms for surveys, analytics platforms (e.g., SimilarWeb, Statista), and expert consultations.
5. Ethical Considerations and Compliance
Ethical Approval: Ensure compliance with ethical guidelines for research involving human subjects.
Data Privacy: Implement measures to protect participant confidentiality and adhere to data protection regulations (e.g., GDPR, HIPAA).
6. Budget and Resource Allocation
Resource Planning: Allocate resources including time, budget, and personnel required for each phase of the research.
Contingency Planning: Anticipate and plan for unforeseen challenges or adjustments to the research plan.
7. Develop Research Instruments
Survey Design: Create well-structured surveys using tools like Google Forms to gather quantitative data.
Interview and Focus Group Guides: Prepare detailed scripts and discussion points for qualitative data collection.
8. Sampling Strategy
Sampling Design: Define the sampling frame, size, and method (e.g., random sampling, stratified sampling) to ensure representation of target demographics.
Participant Recruitment: Plan recruitment strategies to reach and engage the intended participant groups effectively.
9. Data Collection and Analysis Plan
Data Collection: Implement methods for data gathering, ensuring consistency and validity.
Analysis Techniques: Decide on analytical approaches (e.g., statistical
Simple Steps to Make Her Choose You Every DayLucas Smith
Simple Steps to Make Her Choose You Every Day" and unlock the secrets to building a strong, lasting relationship. This comprehensive guide takes you on a journey to self-improvement, enhancing your communication and emotional skills, ensuring that your partner chooses you without hesitation. Forget about complications and start applying easy, straightforward steps that make her see you as the ideal person she can't live without. Gain the key to her heart and enjoy a relationship filled with love and mutual respect. This isn't just a book; it's an investment in your happiness and the happiness of your partner
Solution manual for managerial accounting 18th edition by ray garrison eric n...rightmanforbloodline
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Solution manual for managerial accounting 18th edition by ray garrison eric noreen and peter brewer_compressed
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
About CentiUP - Product Information Slide.pdfCentiUP
A heightened child formula, with the trio of Nano Calcium, HMO, and DHA mixed in the golden ratio, combined with NANO technology to help nourish the body deeply and comprehensively, helps children increase height, boost brain power, and improve the immune system and overall well-being.
Test bank calculating drug dosages a patient safe approach to nursing and mat...rightmanforbloodline
Test bank calculating drug dosages a patient safe approach to nursing and math 2nd edition by castillo werner mccullough
Test bank calculating drug dosages a patient safe approach to nursing and math 2nd edition by castillo werner mccullough
Test bank calculating drug dosages a patient safe approach to nursing and math 2nd edition by castillo werner mccullough
Test bank calculating drug dosages a patient safe approach to nursing and mat...
Zika virus
1.
2. Zika virus was first discovered in 1947 and is named after the Zika Forest in
Uganda. In 1952, the first human cases of Zika were detected and since then,
outbreaks of Zika have been reported in tropical Africa, Southeast Asia, and the
Pacific Islands.
Zika outbreaks have probably occurred in many
locations. Before 2007, at least 14 cases
of Zika had been documented, although other
cases were likely to have occurred and
were not reported. Because the symptoms of Zika
are similar to those of many other diseases, many
cases may not have been recognized.
3. Zika virus is a mosquito-borne flavivirus
that was first identified in Uganda in 1947 in
monkeys through a network that monitored
yellow fever.
Zika virus disease is caused by a virus
transmitted primarily by Aedes mosquitoes.
People with Zika virus disease can have
symptoms including mild fever, skin rash,
conjunctivitis, muscle and joint pain,
malaise or headache. These symptoms
normally last for 2-7 days.
4. The CDC has also confirmed that a Zika virus can spread through
sex, usually after a person traveled to an area where Zika has
broken out, got the virus, and gave the virus to a sex partner who
did not travel. Infected women and men can both pass the virus to
sex partners -- even if they haven’t shown symptoms of infection,
the CDC says. In addition, infected pregnant women can pass the
virus on to their fetus.
5. Symptoms can appear anywhere from 3 to 14 days
after a bite from an infected mosquito, according
to the CDC. They can last from several
days to about a week.
Symptoms can last for several days to a week.
People usually don’t get sick enough to go to the hospital, and they very
rarely die of Zika. Once a person has been infected with Zika, they are
likely to be protected from future infections.
6. Zika infection during pregnancy can cause a birth
defect of the brain called microcephaly and other
severe fetal brain defects. Other problems have been
detected among fetuses and infants infected with Zika
virus before birth, such as defects of the eye, hearing
deficits, and impaired growth. There have also been
increased reports of Guillain-Barré syndrome, an
uncommon sickness of the nervous system, in areas
affected by Zika.
7. The best way to prevent diseases spread by mosquitoes is to protect yourself and your
family from mosquito bites.
Clothing
Wear long-sleeved shirts and long pants.
Treat your clothing and gear with permethrin or buy pre-treated items.
Sexual transmission
Prevent sexual transmission of Zika by using condom.
8. Insect repellent
Use Environmental Protection Agency (EPA)-registered insect repellents
When used as directed, these insect repellents are proven safe and effective even for
pregnant and breastfeeding women.
Do not use insect repellents on babies younger than 2 months old.
Do not use products containing oil of lemon eucalyptus or para-menthane-diol on children
younger than 3 years old.
At home
Stay in places with air conditioning and window and door screens to keep mosquitoes
outside.
Take steps to control mosquitoes inside and outside your home.
Mosquito netting can be used to cover babies younger than 2 months old in carriers,
strollers, or cribs.
Sleep under a mosquito bed net if air conditioned or screened rooms are not available or if
sleeping outdoors.
9. Get plenty of rest.
Drink fluids to prevent dehydration.
Take medicine such as acetaminophen to reduce fever
and pain.
Do not take aspirin or other non-steroidal anti-
inflammatory drugs (NSAIDs).
If you are taking medicine for another medical
condition, talk to your healthcare provider before taking
additional medication.